Angela R. Winnier

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Carlos L. Arteaga, Stephen D. Hurd, Angela R. Winnier et al. · Journal of Clinical Investigation · 1993 · 357 citations · Full text

Spleen Natural Killer, Breast Oncology, Immunology +17

p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.

Carlos L. Arteaga, Angela R. Winnier, Miriam C. Poirier et al. · PubMed · 1994 · 128 citations

Tumor Biology, Tab 250, Medicine +13

UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans

Angela R. Winnier, James Y. Meir, Jennifer M. Ross et al. · Genes & Development · 1999 · 125 citations · Full text

The epidermal growth factor receptor is associated with phospholipase C-γ1 in meningiomas

Mahlon D. Johnson, Megumi Horiba, Angela R. Winnier et al. · Human Pathology · 1994 · 49 citations

Molecular Physiology, Signal Transduction, Signaling Pathway +8

Evidence for a positive role of transforming growth factor-β in human breast cancer cell tumorigenesis

Carlos L. Arteaga, Teresa C. Dugger, Angela R. Winnier et al. · Journal of Cellular Biochemistry · 1993 · 26 citations